Stock daily read

What happened with GXAI today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

GXAI in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Most of Gaxos.ai Inc.’s revenue comes from RNK Health, which handles the non-clinical work surrounding telehealth care, such as scheduling, patient intake, care navigation and patient education. A third-party Medical Partner provides the medical professionals and care, collects payment and remits RNK Health’s commission. This makes the business dependent on that partner accepting patients, delivering care and passing on the commission; RNK Health does not itself provide the medical services.

AI application subscriptions are the next-largest revenue source, through Art-Gen.ai, unGPT.ai and Bible.ai. The company also offers Gaxos Labs to game developers and publishers, who pay usage-based subscriptions for software that generates game content. Gaxos Labs also provides customized image- and sound-generation models and consulting. Health coaching and in-game item sales contribute little revenue.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in GXAI’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

GXAI says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Gaxos.AI’s results hinge mainly on RNK Health’s administrative-service commissions and its unnamed third-party Medical Partner, which must accept patients, provide care, and collect and remit those commissions.

  • Gaxos.AI relies on Alphabet’s Google AI models alongside its own enhancements for Art-Gen.AI, an image and video creation service included in its paid app subscriptions. For this connection, watch the Google models used in Art-Gen.AI rather than Google Services’ core business of selling ads to advertisers.

Agenda

in 8 daysWed, Oct 28

  1. Time to be announced

    Alphabet Inc. earningsGOOG

    Alphabet’s report offers context on whether the Google AI models used in Gaxos.ai’s paid Art-Gen.AI subscriptions remain a supported input.

in 23 daysThu, Nov 12

  1. Time to be announced
    Major

    Gaxos.ai Inc. earningsThis company

    Gaxos.ai’s report will show whether RNK Health can turn its medical partner’s care into recurring administrative-services commissions.